
Kwality Pharmaceuticals shares jumped over 20% on NSE to Rs 3,134 after the company reported consolidated net profit of Rs 25.6 crore for the June quarter, more than double the Rs 11.9 crore a year ago. Revenue from operations rose 45.7% to Rs 162 crore from Rs 112 crore, NDTV Profit reports.
Operating EBITDA increased 69.1% to Rs 41.1 crore, with margins expanding to 25.3% from 21.8%. The stock has gained over 85% since the start of 2026. Its 52-week range is Rs 1,561 to Rs 3,134.1, giving it a market cap of Rs 3,252 crore.
The usual narrative around pharma stocks is that a single good quarter triggers a buying frenzy, but Kwality Pharma's sustained rally since early 2026 shows broader confidence in its execution. The key test now is whether it can maintain this EBITDA margin above 25% while revenue growth stays near 45%. Watch next quarter's numbers for margin stability, not just profit doubling.
Source: ndtvprofit.com
This story was synthesised by AI from the source linked above. Methodology and corrections.
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.